{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:31:50Z","timestamp":1787167910517,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jvacx.2023.100410","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T21:17:25Z","timestamp":1700515045000},"page":"100410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Long-term immunity induced by SPBN GASGAS in orally vaccinated dogs is non-inferior to inactivated rabies vaccines"],"prefix":"10.1016","volume":"15","author":[{"given":"Ad","family":"Vos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwicha","family":"Kasemsuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kansuda","family":"Leelahapongsathon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Bobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Perez-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Kliemt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinya","family":"Phawaphutayanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirut","family":"Aiyara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad M.","family":"Freuling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0959-3653","authenticated-orcid":false,"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2023.100410_b0005","unstructured":"Committee for Veterinary Medicinal Products. Note for Guidance: Duration of protection achieved by veterinary vaccines. EMEA\/CVMP\/682\/99-Final; 2000."},{"issue":"1","key":"10.1016\/j.jvacx.2023.100410_b0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.vetmic.2006.04.014","article-title":"Duration of immunity (DOI)\u2013The regulatory issues","volume":"117","author":"Gaskell","year":"2006","journal-title":"Vet microbiol"},{"issue":"3","key":"10.1016\/j.jvacx.2023.100410_b0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vaccine.2007.11.029","article-title":"Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies","volume":"26","author":"Zhang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2023.100410_b0020","article-title":"Efficacy studies with SAD B19 in Turkish dogs","author":"Aylan","year":"1998","journal-title":"J Etlik Vet Microbiol"},{"issue":"17","key":"10.1016\/j.jvacx.2023.100410_b0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.vaccine.2006.12.054","article-title":"The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs","volume":"25","author":"Cliquet","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2023.100410_b0030","first-page":"257","article-title":"Efficacy of a square presentation of V-RG vaccine baits in red fox, domestic dog and raccoon dog","volume":"131","author":"Cliquet","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.jvacx.2023.100410_b0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2015.06.011","article-title":"Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination","volume":"121","author":"Shuai","year":"2015","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.jvacx.2023.100410_b0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/vaccines11020307","article-title":"Efficacy of Oral Rabies Vaccine Baits Containing SPBN GASGAS in Domestic Dogs According to International Standards","volume":"11","author":"Bobe","year":"2023","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.jvacx.2023.100410_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/v11090790","article-title":"Long-Term Immunogenicity and Efficacy of the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Foxes","volume":"11","author":"Freuling","year":"2019","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.jvacx.2023.100410_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10091384","article-title":"Bridging Animal and Human Data in Pursuit of Vaccine Licensure","volume":"10","author":"Finch","year":"2022","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.jvacx.2023.100410_b0055","doi-asserted-by":"crossref","first-page":"857","DOI":"10.20506\/rst.22.3.1437","article-title":"Neutralising antibody titration in 25,000 sera of dogs and cats vaccinated against rabies in France, in the framework of the new regulations that offer an alternative to quarantine","volume":"22","author":"Cliquet","year":"2003","journal-title":"Rev Sci Tech"},{"issue":"51","key":"10.1016\/j.jvacx.2023.100410_b0060","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.1016\/j.vaccine.2007.10.015","article-title":"Factors influencing the antibody response of dogs vaccinated against rabies","volume":"25","author":"Kennedy","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jvacx.2023.100410_b0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S1466252310000150","article-title":"Duration of immunity induced by companion animal vaccines","volume":"11","author":"Roth","year":"2010","journal-title":"Anim Health Res Rev"},{"issue":"33","key":"10.1016\/j.jvacx.2023.100410_b0070","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1016\/j.vaccine.2017.09.096","article-title":"Evaluation of immune responses in dogs to oral rabies vaccine under field conditions","volume":"37","author":"Smith","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2023.100410_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.737250","article-title":"Immunogenicity of the Oral Rabies Vaccine Strain SPBN GASGAS in Dogs Under Field Settings in Namibia","volume":"8","author":"Molini","year":"2021","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.jvacx.2023.100410_b0080","doi-asserted-by":"crossref","unstructured":"Megawati Saputra IL, Suwarno S, Husein WF, Suseno PP, Prayoga IMA, Vos A et al. Immunogenicity of Oral Rabies Vaccine Strain SPBN GASGAS in Local Dogs in Bali, Indonesia. Viruses 2023;15(6). https:\/\/doi.org\/10.3390\/v15061405.","DOI":"10.3390\/v15061405"},{"issue":"7","key":"10.1016\/j.jvacx.2023.100410_b0085","doi-asserted-by":"crossref","first-page":"e0254192","DOI":"10.1371\/journal.pone.0254192","article-title":"Large scale dog population demography, dog management and bite risk factors analysis: A crucial step towards rabies control in Cambodia","volume":"16","author":"Chevalier","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jvacx.2023.100410_b0090","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/vaccines8040573","article-title":"Humoral Immune Response of Thai Dogs after Oral Vaccination against Rabies with the SPBN GASGAS Vaccine Strain","volume":"8","author":"Leelahapongsathon","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.jvacx.2023.100410_b0095","doi-asserted-by":"crossref","unstructured":"Borutzki S, Richter B, Proemmel M, Fabianska I, Tran HQ, Hundt B et al. Oral Rabies Vaccine Strain SPBN GASGAS: Genetic Stability after Serial In Vitro and In Vivo Passaging. Viruses 2022;14(10). https:\/\/doi.org\/10.3390\/v14102136.","DOI":"10.3390\/v14102136"},{"issue":"2","key":"10.1016\/j.jvacx.2023.100410_b0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jviromet.2012.11.022","article-title":"Evaluation of an ELISA to detect rabies antibodies in orally vaccinated foxes and raccoon dogs sampled in the field","volume":"187","author":"Wasniewski","year":"2013","journal-title":"J Virol Methods"},{"issue":"31","key":"10.1016\/j.jvacx.2023.100410_b0105","article-title":"Rabies Virus Antibodies from Oral Vaccination as a Correlate of Protection against Lethal Infection in Wildlife","volume":"2","author":"Moore","year":"2017","journal-title":"Trop Med Infect Dis"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100410_b0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.vetmic.2006.04.013","article-title":"Duration of immunity for canine and feline vaccines: a review","volume":"117","author":"Schultz","year":"2006","journal-title":"Vet Microbiol"},{"issue":"11","key":"10.1016\/j.jvacx.2023.100410_b0115","first-page":"1491","article-title":"Rabies Vaccines - Duration-Of-Immunity Study in Dogs","volume":"159","author":"Sikes","year":"1971","journal-title":"J Am Vet Med Assoc"},{"issue":"5","key":"10.1016\/j.jvacx.2023.100410_b0120","first-page":"e226","article-title":"Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging","volume":"16","author":"Lowy","year":"2015","journal-title":"LancetOncol"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100410_b0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41541-020-00261-9","article-title":"Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate","volume":"5","author":"Roozendaal","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"2","key":"10.1016\/j.jvacx.2023.100410_b0130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3201\/eid2902.221422","article-title":"Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection","volume":"29","author":"Khoury","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"49","key":"10.1016\/j.jvacx.2023.100410_b0135","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1016\/j.vaccine.2012.09.068","article-title":"Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine","volume":"30","author":"Jas","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jvacx.2023.100410_b0140","first-page":"153","article-title":"Duration of immunity after rabies vaccination in dogs: The Rabies Challenge Fund research study","volume":"84","author":"Dodds","year":"2020","journal-title":"Can J Vet Res"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100410_b0145","first-page":"39","article-title":"Duration of immunity in foxes vaccinated orally with ERA vaccine in a bait","volume":"61","author":"Lawson","year":"1997","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.jvacx.2023.100410_b0150","first-page":"153","article-title":"Canine vaccines","author":"Tizard","year":"2020","journal-title":"Vaccines for Veterinarians"},{"issue":"33","key":"10.1016\/j.jvacx.2023.100410_b0155","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1016\/j.vaccine.2017.09.093","article-title":"Efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes and raccoon dogs","volume":"37","author":"Freuling","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2023.100410_b0160","series-title":"History of Rabies in the Americas: From the Pre-Columbian to the Present","first-page":"77","article-title":"Historical Laboratory Contributions Supporting Rabies Diagnosis and Disease Prevention and Control in the Americas","author":"NadinDavis","year":"2023"},{"issue":"3","key":"10.1016\/j.jvacx.2023.100410_b0165","doi-asserted-by":"crossref","first-page":"735","DOI":"10.20506\/rst.11.3.622","article-title":"Practical significance of rabies antibodies in cats and dogs","volume":"11","author":"Aubert","year":"1992","journal-title":"Rev Sci Tech"},{"issue":"3","key":"10.1016\/j.jvacx.2023.100410_b0170","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1371\/journal.pntd.0000595","article-title":"Rabies-Specific Antibodies: Measuring Surrogates of Protection against a Fatal Disease","volume":"4","author":"Moore","year":"2010","journal-title":"PLoS Neglect Trop Dis"},{"key":"10.1016\/j.jvacx.2023.100410_b0175","unstructured":"European Pharmacopoeia 10.0. Rabies vaccine (live, oral) for foxes and raccoon dogs 01\/2014-0746. European Directorate for the Quality of Medicines, Strasbourg: European Council:1050\u20131; 2019."},{"key":"10.1016\/j.jvacx.2023.100410_b0180","unstructured":"World Organisation for Animal Health (ed.). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2021. 8th ed; 2018."},{"issue":"1","key":"10.1016\/j.jvacx.2023.100410_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9010049","article-title":"Comparable Long-Term Rabies Immunity in Foxes after IntraMuscular and Oral Application Using a Third-Generation Oral Rabies Virus Vaccine","volume":"9","author":"Te Kamp","year":"2021","journal-title":"Vaccines"},{"issue":"18","key":"10.1016\/j.jvacx.2023.100410_b0190","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1073\/pnas.0609122104","article-title":"Synchronous cycles of domestic dog rabies in sub-Saharan Africa and the impact of control efforts","volume":"104","author":"Hampson","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.jvacx.2023.100410_b0195","doi-asserted-by":"crossref","first-page":"e0167092","DOI":"10.1371\/journal.pone.0167092","article-title":"Ecology and Demography of Free-Roaming Domestic Dogs in Rural Villages near Serengeti National Park in Tanzania","volume":"11","author":"Czupryna","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jvacx.2023.100410_b0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0147-9571(82)90047-9","article-title":"Ecology of dogs in the Central Philippines in relation to rabies control efforts","volume":"5","author":"Beran","year":"1985","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"16","key":"10.1016\/j.jvacx.2023.100410_b0205","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/vr.147.16.442","article-title":"Demography and dog-human relationships of the dog population in Zimbabwean communal lands","volume":"147","author":"Butler","year":"2000","journal-title":"Vet Rec"},{"issue":"3","key":"10.1016\/j.jvacx.2023.100410_b0210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0001-706X(01)00082-1","article-title":"Dog ecology and demography information to support the planning of rabies control in Machakos District","volume":"78","author":"Kitala","year":"2001","journal-title":"Kenya Acta Trop"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223001511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223001511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T03:15:22Z","timestamp":1719976522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136223001511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":42,"alternative-id":["S2590136223001511"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100410","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term immunity induced by SPBN GASGAS in orally vaccinated dogs is non-inferior to inactivated rabies vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100410"}}